Metoclopramide Noridem

Metoclopramide, the active ingredient in Metoclopramide Noridem, is a dopamine D2 receptor antagonist presented as an injectable solution for intramuscular and intravenous use. It treats nausea and vomiting, including postoperative and chemotherapy‑induced cases, and aids gastric emptying in gastroparesis.

GNH USA supplies Metoclopramide Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Metoclopramide is employed as an antiemetic and gastro‑prokinetic agent across several clinical situations.

- Nausea and vomiting: reduces episodes by blocking dopamine receptors in the chemoreceptor trigger zone. - Post‑operative nausea and vomiting: prevents and treats nausea after surgical procedures. - Gastroparesis: enhances gastric motility and accelerates stomach emptying. - Chemotherapy‑induced nausea: alleviates nausea associated with cytotoxic cancer therapy.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: mild agitation or inability to stay still. - Dry mouth: reduced salivation leading to a parched sensation.

Serious or Rare Side Effects: - Extrapyramidal symptoms: muscle rigidity, dystonia, or akathisia. - Tardive dyskinesia: persistent involuntary movements, especially with prolonged use. - Neuroleptic malignant syndrome: rare but life‑threatening hyperthermia and muscle breakdown.

Before using Metoclopramide Noridem, consider the following safety measures.

- Renal impairment: adjust use or monitor closely. - Elderly patients: increased risk of extrapyramidal effects; use the lowest effective dose. - History of movement disorders: avoid or use with caution. - Concomitant CNS depressants: monitor for enhanced sedation. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metoclopramide can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine blockade may increase extrapyramidal symptoms. - Monoamine oxidase inhibitors: risk of hypertensive crisis. - CYP2D6 inhibitors (e.g., fluoxetine): may raise metoclopramide plasma levels.

Moderate Interactions (Monitor Closely): - Opioids: may enhance nausea control but increase sedation. - Anticholinergics: may reduce the pro‑kinetic effect. - Alcohol: may increase central nervous system depression.